MOUNTAIN VIEW, Calif., Sept. 15 /PRNewswire-FirstCall/ -- Pharsight Corporation (OTC Bulletin Board: PHST - News), a leading provider of software and strategic services designed to optimize clinical drug development, today announced that it has signed a cooperation agreement with LabLogic Systems Limited to enhance the link between Debra, LabLogic’s drug metabolism Laboratory Information Management System, and Pharsight’s WinNonlin software for pharmacokinetic, pharmacodynamic and non-compartmental analysis.
